Oklahoma City — Oklahoma City, Oklahoma

Oklahoma City is a clinical research site located in Oklahoma City, Oklahoma, United States 73103.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Oklahoma City has participated in 10 clinical trials with 1 currently active.

Therapeutic areas: PTSD, Seizures, Prostate Cancer.

Sponsors: Tonix Pharmaceuticals, Inc., AbbVie, Myovant Sciences GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma City?

Oklahoma City has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma City conducted?

Oklahoma City has 10 clinical trials on record, with 1 currently active. Their work covers PTSD, Seizures, Prostate Cancer.

Is Oklahoma City accredited by Crixeo Clinical Trials?

Oklahoma City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.